Orient Pharma Co., Ltd.
4166.TWO
Price:
$24.95
Market Cap:
$5.62B
Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson's and Alzheimer's diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and micro granules. The company was founded in 2008 and is based in Taipei, Taiwan.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-06-20
Stock Exchange
TWO
Ticker
4166.TWO
PE Ratio
[43.77]
ROE
[6.12%]
Current Ratio
[5.33]
Dividend Yield
[0%]
Enterprise Value
[5.29B]
Dividend History
The Current Ratio as of December 2025 (TTM) for Orient Pharma Co., Ltd. (4166.TWO) is 5.33
According to Orient Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 5.33. This represents a change of 107.33% compared to the average of 2.57 of the last 4 quarters.
Orient Pharma Co., Ltd. (4166.TWO) Historical Current Ratio (quarterly & annually)
How has 4166.TWO Current Ratio performed in the past?
The mean historical Current Ratio of Orient Pharma Co., Ltd. over the last ten years is 1.25. The current 5.33 Current Ratio has changed 42.50% with respect to the historical average. Over the past ten years (40 quarters), 4166.TWO's Current Ratio was at its highest in in the September 2025 quarter at 5.33. The Current Ratio was at its lowest in in the March 2023 quarter at 1.06.
Average
1.25
Median
1.15
Minimum
0.91
Maximum
1.73
Orient Pharma Co., Ltd. (4166.TWO) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Orient Pharma Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 89.65%
Maximum Annual Current Ratio = 1.73
Minimum Annual Increase = -39.59%
Minimum Annual Current Ratio = 0.91
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 1.49 | 35.35% |
| 2023 | 1.10 | -8.36% |
| 2022 | 1.21 | 15.08% |
| 2021 | 1.05 | -39.59% |
| 2020 | 1.73 | 89.65% |
Orient Pharma Co., Ltd. (4166.TWO) Average Current Ratio
How has 4166.TWO Current Ratio performed in the past?
The current Current Ratio of Orient Pharma Co., Ltd. (4166.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.27
5-year avg
1.32
10-year avg
1.25
Orient Pharma Co., Ltd. (4166.TWO) Current Ratio vs. Peers
How is 4166.TWO’s Current Ratio compared to its peers?
Orient Pharma Co., Ltd.’s Current Ratio is greater than Panion & Bf Biotech Inc. (1.41), greater than BIONET Corp. (4.20), greater than Easywell Biomedicals, Inc. (2.62), greater than SCI Pharmtech, Inc. (1.10), greater than Formosa Optical Technology Co.,Ltd. (1.51), greater than Brighten Optix Corporation (2.59), less than Ever Fortune.AI Co., Ltd. (7.89), greater than Hi-Clearance Inc. (1.70), less than Savior Lifetec Corporation (10.62), greater than Orient EuroPharma Co., Ltd. (1.65),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.41 | $5.45B | |
| 4.20 | $5.23B | |
| 2.62 | $4.20B | |
| 1.10 | $5.77B | |
| 1.51 | $6.40B | |
| 2.59 | $5.41B | |
| 7.89 | $6.42B | |
| 1.70 | $6.10B | |
| 10.62 | $5.51B | |
| 1.65 | $3.76B |
Build a custom stock screener for Orient Pharma Co., Ltd. (4166.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orient Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Orient Pharma Co., Ltd. (4166.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Orient Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Orient Pharma Co., Ltd.'s Current Ratio?
How is the Current Ratio calculated for Orient Pharma Co., Ltd. (4166.TWO)?
What is the highest Current Ratio for Orient Pharma Co., Ltd. (4166.TWO)?
What is the 3-year average Current Ratio for Orient Pharma Co., Ltd. (4166.TWO)?
What is the 5-year average Current Ratio for Orient Pharma Co., Ltd. (4166.TWO)?
How does the current Current Ratio for Orient Pharma Co., Ltd. (4166.TWO) compare to its historical average?